SCHEMBL7939490

SCHEMBL7939490

O=C(Cc1ccccc1-c1ccccc1)NCl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
LMNA P02545 1/20 0.51
RAB9A P51151 1/20 0.51
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
DPP4 P27487 1/20 0.46
FOLH1 Q04609 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
HDAC3 O15379 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2397419 0.82 KMT2A (0.51) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL5249556 0.82 KMT2A (0.51) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL8639463 0.81 CYP1A2 (0.63) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL3111571 0.79 KMT2A (0.56) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL538512 0.79 KMT2A (0.60) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL3437801 0.79 KMT2A (0.60) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL27750565 0.78 LMNA (0.51) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL28594606 0.77 KMT2A (0.58) KMT2ALMNARAB9AFFAR1FFAR4
Hydrochloric Acid SCHEMBL11895689 0.77 KMT2A (0.58) KMT2ALMNARAB9AFFAR1FFAR4
SCHEMBL29512995 0.77 KMT2A (0.58) KMT2ALMNARAB9AFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245817-B1 NEUROPEPTIDE Y BAYER CORPORATION 2001-06-12 US disclosed
US-5939462-A ADMINISTERING ALKOXY AND -THIOALKOXYAMIDE COMPOSITIONS TO MAMMALS TO TREAT DISORDERS SUCH AS OBESITY THAT ARE MEDIATED BY NEUROPEPTIDE Y (?NPY?) BAYER CORPORATION (US) 1999-08-17 US disclosed
EP-0927166-A1 AMIDES AS NPY5 RECEPTOR ANTAGONISTS Bayer Corporation (US) 1999-07-07 EP disclosed
WO-1998035944-A1 AMIDES AS NPY5 RECEPTOR ANTAGONISTS BAYER CORPORATION (US) 1998-08-20 WO disclosed